Too Few Asthma Patients Are Using Updated Inhalers
WEDNESDAY, May 22, 2024 -- Improved inhalers are now available to help control asthma and treat sudden attacks, but a new study shows that hardly anyone ’s using them.The new inhalers combine inflammation-fighting corticosteroids with a... (Source: - Daily MedNews)
Source: - Daily MedNews - May 22, 2024 Category: General Medicine Source Type: news

Beta-Blocker Fails to Prevent COPD Exacerbations
(MedPage Today) -- SAN DIEGO -- The beta-blocker bisoprolol did not improve exacerbations in chronic obstructive pulmonary disease (COPD) patients, a randomized clinical trial found. Exacerbations requiring antibiotics, oral corticosteroids... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - May 21, 2024 Category: Allergy & Immunology Source Type: news

Bisoprolol Does Not Reduce Exacerbations in At-Risk COPD Patients
MONDAY, May 20, 2024 -- For patients with chronic obstructive pulmonary disease (COPD), bisoprolol does not reduce the number of self-reported exacerbations treated with oral corticosteroids, antibiotics, or both, according to a study published... (Source: - Pharma News)
Source: - Pharma News - May 20, 2024 Category: Pharmaceuticals Source Type: news

What Are Treatment Options for EOE?
Discussion Eosinophilic esophagitis (EOE) is a clinicopathologic condition of the esophagus where a pediatric or adult patient has clinical symptoms of esophageal dysfunction along with 15 or more eosinophils per high powered field in histological samples. The clinical diagnosis is difficult because many presenting symptoms are consistent with gastroesophageal reflux disease (GERD). Clinical features in children include feeding intolerance or refusal, abdominal pain, emesis or reflux symptoms. Other symptoms include chest pain, diarrhea or failure to thrive. Older children and adolescents may have food impaction or dysphag...
Source: - May 6, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Interstitial lung abnormalities linked to respiratory disease risk
CT imaging shows that severe acute respiratory disease events can be caused by quantitative interstitial abnormalities (QIA) -- that is, small irregularities that don't necessarily meet diagnostic criteria for advanced pulmonary diseases but show up on CT exams over time, a study published April 30 in Radiology has reported. A team led by Bina Choi, MD, of Brigham and Women’s Hospital in Boston found that, although acute respiratory disease events have tended to be associated with airway disease, "progression in QIA is independently associated with these acute respiratory disease events both intercurrent and subsequent ...
Source: Headlines - April 30, 2024 Category: Radiology Authors: Kate Madden Yee Tags: CT Source Type: news

Antenatal Corticosteroids Do Not Negatively Impact Offspring
FRIDAY, April 26, 2024 -- Administration of antenatal corticosteroids to persons at risk for late preterm delivery is not associated with adverse childhood neurodevelopmental outcomes at age 6 years or older, according to a study published online... (Source: - Pharma News)
Source: - Pharma News - April 26, 2024 Category: Pharmaceuticals Source Type: news

Why Is It So Bad to Pop a Pimple?
It’s tough to resist squeezing a juicy pimple. You probably want to get rid of it quickly and may feel like you know exactly how to do it after having watched hundreds of pimple-popping videos online. Dermatologists get the temptation, but say you should leave your zits alone. “As a general rule, you shouldn’t pop your pimples,” says Dr. Jody Alpert Levine, a dermatologist and director of dermatology at Plastic Surgery & Dermatology of NYC.  [time-brightcove not-tgx=”true”] Pimples form when excess oil, bacteria, and dirt clog hair follicles. When the trapped follicles s...
Source: TIME: Health - April 25, 2024 Category: Consumer Health News Authors: Erica Sweeney Tags: Uncategorized Evergreen freelance healthscienceclimate Source Type: news

Portland biotech Sparrow Pharmaceuticals raises $10M to further clinical trials
Sparrow Pharmaceuticals is developing, novel targeted therapies for disorders caused by excess corticosteroids. (Source: Health Care:Pharmaceuticals headlines)
Source: Health Care:Pharmaceuticals headlines - April 24, 2024 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Orally Inhaled and Intranasal Corticosteroids: Evaluation of the Effects on Growth in Children
Clinical/Medical (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 11, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

What are the benefits and risks of different corticosteroid treatments delivered intravenously for the prevention of bronchopulmonary dysplasia in infants born prematurely?
Wednesday, April 3, 2024 (Source: Cochrane News and Events)
Source: Cochrane News and Events - April 3, 2024 Category: Information Technology Authors: Paolo Rosati Source Type: news

Should You Give Injectables a Shot for Osteoarthritis Pain?
A number of injectables, including corticosteroids and hyaluronic acid, are available to help treat painful knee osteoarthritis. (Source: WebMD Health)
Source: WebMD Health - April 1, 2024 Category: Consumer Health News Source Type: news

Oral Corticosteroids Ease Preschoolers' Acute Wheeze
(MedPage Today) -- Oral corticosteroids helped reduce wheeze severity and length of hospital stay in children experiencing acute preschool wheeze, a pooled analysis of patient-level randomized trial data showed. The medication reduced wheezing... (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - March 29, 2024 Category: Pediatrics Source Type: news

Comparative analysis of CRASH and IMPACT in predicting the outcome of 340 patients with traumatic brain injury - An T, Dong Z, Li X, Ma Y, Jin J, Li L, Xu L.
BACKGROUND: Both the International Mission for Prognosis and Analysis of Clinical Trials (IMPACT) and the Corticosteroid randomization after significant head injury (CRASH) models are globally acknowledged prognostic algorithms for assessing traumatic brai... (Source: SafetyLit)
Source: SafetyLit - March 28, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Promising Phase 3 Data on DMD Hopeful Givinostat Promising Phase 3 Data on DMD Hopeful Givinostat
Treatment with the investigational agent givinostat has the potential to delay disease progression when added to corticosteroid treatment in ambulatory boys with Duchenne muscular dystrophy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 21, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

The effect of oral analgesic premedication on the success rate of inferior alveolar nerve block for teeth with irreversible pulpitis: A randomized clinical trial
Conclusions: Premedication with pharmapain (an anti-inflammatory agent) and dexamethasone (a corticosteroid) does not enhance the success rate of the IANB technique in mandibular molars with irreversible pulpitis compared to placebo. However, the use of dexamethasone was significantly more effective than pharmapain in reducing pain severity at inserting endodontic files. (Source: Dental Technology Blog)
Source: Dental Technology Blog - March 19, 2024 Category: Dentistry Source Type: news